⮝ Full datasets listing

PXD067174

PXD067174 is an original dataset announced via ProteomeXchange.

Dataset Summary
TitleDevelopment and Validation of a Proteomics and Machine Learning-Based Predictive Model for Secondary Infection in Patients with HBV-Related Liver Failure: A Prospective Multicenter Study
DescriptionAbstract Background and Aims: Patients with HBV-related cirrhosis are highly susceptible to secondary infections (SI) during hospitalization, which substantially increases mortality risk. Reliable tools for early prediction remain limited. This study aimed to develop and validate a multi-parameter predictive model based on plasma proteomic profiling to assess the risk of SI. Methods: In a prospective, multicenter cohort study, 114 patients were enrolled in the discovery cohort and 60 in the validation cohort. Differentially expressed proteins were identified using untargeted plasma proteomics. Feature selection was performed using the minimum redundancy maximum relevance (mRMR) algorithm, and logistic regression was applied to construct the predictive model. Model performance was subsequently validated in an independent cohort using targeted proteomics. Results: Proteomic analysis indicated that dysregulation of inflammatory and coagulation pathways contributes to SI development. Ten infection-associated proteins were selected, and a final predictive model incorporating LYZ, CALM1, SERPIND1, DPT, total bilirubin (Tbil), and aspartate aminotransferase (AST) was established. The model achieved an area under the receiver operating characteristic curve (AUROC) of 0.980 in the discovery cohort and 0.873 in the validation cohort, significantly outperforming conventional inflammatory markers such as C-reactive protein (CRP; 0.674 and 0.702), white blood cell count (WBC; 0.645 and 0.694), and neutrophil percentage (NE%; 0.642 and 0.793). The model also demonstrated strong prognostic performance for predicting 28-day mortality, with an AUROC of 0.957, exceeding that of the Chronic Liver Failure Consortium Acute-on-Chronic Liver Failure (CLIF-C ACLF) score (0.545) and the Model for End-stage Liver Disease (MELD) score (0.824). Conclusions: The proteomics-based predictive model accurately identifies patients with HBV-related liver failure at high risk of SI, offering promising clinical applicability and generalizability.
HostingRepositoryiProX
AnnounceDate2025-08-08
AnnouncementXMLSubmission_2025-12-28_19:46:49.882.xml
DigitalObjectIdentifier
ReviewLevelPeer-reviewed dataset
DatasetOriginOriginal dataset
RepositorySupportUnsupported dataset by repository
PrimarySubmitterFeixiang Xiong
SpeciesList scientific name: Homo sapiens; NCBI TaxID: 9606;
ModificationListNo PTMs are included in the dataset
InstrumentOrbitrap Astral
Dataset History
RevisionDatetimeStatusChangeLog Entry
02025-08-10 21:09:04ID requested
12025-12-28 19:46:50announced
Publication List
Dataset with its publication pending
Keyword List
submitter keyword: secondary infections, prognostic biomarkers, prediction model, proteomics
Contact List
Yixin Hou
contact affiliationCenter of Integrative Medicine, Beijing Ditan Hospital, Capital Medical University
contact emailxuexin162@163.com
lab head
Feixiang Xiong
contact affiliationCenter of Integrative Medicine, Beijing Ditan Hospital, Capital Medical University
contact emailxiangakb@163.com
dataset submitter
Full Dataset Link List
iProX dataset URI